Platinum-based agents exert the function by binding to DNAs to interfere with their replication, thereby preventing the division and growth of tumor cells. As a second-generation platinum-based agent, nedaplatin is more dissoluble in water and appears to be less toxic to the kidneys and the digestive system, and therefore more suitable for elderly patients as well as patients with renal insufficiency.